Lean Muscle & Growth Peptides – Research Compounds

Mechanisms

How the growth-hormone axis is studied

Rather than administering growth hormone directly, this research uses secretagogues — compounds prompting the body's own pulsatile release. CJC-1295 w DAC is a long-acting GHRH analogue studied for sustained GH and IGF-1 elevation, with recovery, lean-mass and sleep-architecture endpoints among its documented research applications. Tesamorelin is also a GHRH analogue but its literature centres on lean-mass preservation alongside visceral adipose tissue, and its research models are structured around the natural nocturnal GH pulse. HCG acts on a different axis entirely, through LH/CG receptors, and appears here for endocrine-support research in lean-mass contexts.

Purist Peptides research compounds in a laboratory setting

Study design

Why the GH pulse shapes study design

Growth-hormone research models are structured around the body's own rhythm, because the largest natural GH pulse occurs in deep sleep and secretagogue studies are designed to align with it. Published models are typically cycled with maintenance phases rather than run indefinitely. Lean-mass research also holds resistance training and protein intake constant — the compounds are studied as one input within that model, not as a substitute for those inputs.

The range

Compounds in this category

The compounds grouped here, each with the pathway it is studied for and the protocol shape most often used.

CJC-1295 w DAC

Long-acting GHRH

A long-acting GHRH analogue studied for sustained GH release and IGF-1 elevation, with documented research endpoints spanning recovery, tissue repair, lipid metabolism and sleep architecture.

Long-acting; studied for sustained rather than pulsatile GH and IGF-1 signalling

View CJC-1295 w DAC

Tesamorelin

GHRH analogue

Published third-party test report available (10 mg). A GHRH analogue studied for lean-mass preservation alongside visceral adipose tissue in the published models

View Tesamorelin

HCG research peptide vial by Purist Peptides

HCG

Gonadotropin analogue

A glycoprotein hormone analogue acting on LH/CG receptors, studied for endocrine support in lean-mass research contexts. Stock is limited.

View HCG

Selection

How to choose

Start from the research question, not the compound name.

If the research question is…	Start with
Sustained, long-acting GH and IGF-1 signalling	CJC-1295 w DAC
Visceral adipose tissue with lean-mass preservation	Tesamorelin
Endocrine support alongside lean-mass research	HCG
Two GH pathways in one protocol	the GH Optimisation Stack pairs CJC-1295 with Tesamorelin
Growth plus cellular energy	the Lean Growth Stack pairs CJC-1295 with MOTS-C

Pre-paired

Stacks built on this category

Two pathways studied in parallel, priced and packaged as one protocol.

GH Optimisation StackCJC-1295 + Tesamorelin — two GH pathways in one protocol.View the stack Lean Growth StackCJC-1295 + MOTS-C — growth signalling plus cellular energy.View the stack

Independent laboratory testing of Purist Peptides research compounds

Verified quality

Tested before it ships

Published third-party test report for Tesamorelin (10 mg) · minimum 99% verified purity on every batch · research literature and reconstitution guidance on each product page · lyophilised, refrigerate 2–8 °C after reconstitution. See Quality Standards.

Tesamorelin 20 mg99.30% · COA PDF

See Quality Standards & all COAs

Questions

Lean Muscle research FAQ

What is the difference between CJC-1295 and Tesamorelin?

Both are GHRH analogues, but their research literature differs. CJC-1295 w DAC is long-acting and studied for sustained GH and IGF-1 elevation. Tesamorelin is shorter-acting and its strongest evidence base concerns visceral adipose tissue alongside lean-mass preservation.

Why are these studied around the sleep period?

The largest natural growth-hormone pulse occurs during deep sleep, so secretagogue research models are designed around that rhythm. The relevant literature is referenced on each product page.

How long is a typical research cycle?

Published study lengths differ by compound and by research model. The relevant literature, reconstitution volumes and handling notes are documented on each product page.

Do these replace training and nutrition?

No. Lean-mass research holds resistance training and protein intake constant so the compound is the measured variable — published models explicitly note maintaining adequate protein intake as a controlled input.

Are these compounds third-party tested?

Yes. Every batch is independently assayed to a minimum of 99% purity, and a published third-party test report is available for Tesamorelin (10 mg), with batch certificates on each product page.

Keep exploring